This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 26446-38-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Hong Kong
Inquiry
26446-38-8 / [3,4-dihydroxy-5-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl hexadecanoate
Standard CAS: 26446-38-8
Multi CAS: Yes
Basic Information
copy
CAS
26446-38-8 copy
Multi CAS
Yes copy
Molecular Formula
C28H52O12 copy
Molecular Weight
580.700000 copy
Exact Mass
580.345877 copy
InChI
InChI=1S/C28H52O12/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-21(31)37-17-20-23(33)26(36)28(18-30,39-20)40-27-25(35)24(34)22(32)19(16-29)38-27/h19-20,22-27,29-30,32-36H,2-18H2,1H3 copy
InChIKey
DZPKXFNXNJJENH-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
40 copy
Fraction Csp3
0.96 copy
Rotatable bonds
20 copy
H-bond acceptors
12 copy
H-bond donors
7 copy
Molar refractivity
142.83 copy
TPSA
195.6 copy
LogP / Solubility
WLOGP
0.64 copy
MLOGP
0.61 copy
XLogP3
3.6 copy
Consensus LogP
1.62 copy
Log S (ESOL)
-2.52 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-4.78 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-6.36 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
Yes copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-5.81 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
8.5 copy